Stetz Gary S.
Interim CEO
Stetz Gary S. has filed 3 SEC Form 4 filings (10 transaction rows) across 2 companies, including HEPA, CNTN, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Stetz Gary S. is listed as Interim CEO at Hepion Pharmaceuticals, Inc. Inside the rolling window, Stetz Gary S. reported 2 open-market purchases totaling $150K in HEPA and 2 open-market sales totaling $258K in CNTN. The largest disclosed transaction in the window is a sale of 62,851 CNTN shares on May 22, 2026, worth $215K.
Companies traded
Other insiders at HEPA
Insider Buying
$150K
reported purchases (SEC code P)
Insider Selling
$258K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Stetz Gary S. made?
Stetz Gary S. has filed 3 SEC Form 4 filings (10 transaction rows) across 2 companies, including HEPA, CNTN since 2026.
Which companies does Stetz Gary S. trade?
Stetz Gary S. has filed SEC Form 4 disclosures for 2 companies, including HEPA, CNTN.
When was Stetz Gary S.'s most recent SEC Form 4 filing?
Stetz Gary S.'s most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Stetz Gary S.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Stetz Gary S. is listed as Interim CEO.
What is Stetz Gary S.'s total buy and sell value in the current window?
Inside the rolling retention window, Stetz Gary S. bought $150K and sold $258K based on SEC Form 4 filings.
What was Stetz Gary S.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 62,851 CNTN shares on 2026-05-22, worth $215K, per SEC Form 4 filings.